We’re still asking people with COVID to jump through far too many hoops to get their hands on Pfizer Inc.’s Paxlovid.

The Centers for Medicare & Medicaid Services (CMS) has said it will announce the next 15 drugs in scope for the second round ...

An innovative approach to healthcare, precision medicine is a new medical model that takes into account individual ...

Nearly half a million Americans received an unpleasant surprise this summer, according to insurance billing data: a new ...

New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...

In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.

Responding to rising mpox cases in Africa, the World Health Organization declared a public health emergency of international ...

Updated COVID-19 vaccine is now available. With another COVID-19 surge likely coming this winter, University of Utah experts ...

Shares of Pfizer Inc. PFE shed 0.27% to $29.75 Wednesday, on what proved to be an all-around dismal trading session for the ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

Nursing homes in New York are being urged to protect residents with the updated COVID-19 vaccine. The NYS Department of ...

Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early diagnosis and ...